Exalenz Bioscience Ltd. develops and markets advanced systems that enable medical specialists to identify specific digestive and liver conditions including helicobacter pylori, testing methods and monitoring of diseases of the liver and gastrointestinal tract.
The company's flagship product, the BreathID System, answers a long-standing need for fast and accurate assessment and monitoring of diseases of the liver and gastrointestinal tract. It measures parts-per-million changes in the molecular 13C/12C ratio of the patient's exhaled breath, continuously, automatically, and in real time.
Based on 0 Reviews
Add Review